Exact Mass: 639.2487

Exact Mass Matches: 639.2487

Found 35 metabolites which its exact mass value is equals to given mass value 639.2487, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

3-Methoxy-5-methyl-[1]naphthoesaeure-{7-[(1-acetyl-aziridin-2-yl)-hydroxy-methyl]-9-(1-formyl-2-oxo-propyl)-3-hydroxy-2-methyl-4,11-dioxo-1,5,8-trioxa-10-aza-spiro[5,5]undec-9-en-2-ylmethylamid}|3-methoxy-5-methyl-[1]naphthoic acid-{7-[(1-acetyl-aziridin-2-yl)-hydroxy-methyl]-9-(1-formyl-2-oxo-propyl)-3-hydroxy-2-methyl-4,11-dioxo-1,5,8-trioxa-10-aza-spiro[5,5]undec-9-en-2-ylmethylamide}

3-Methoxy-5-methyl-[1]naphthoesaeure-{7-[(1-acetyl-aziridin-2-yl)-hydroxy-methyl]-9-(1-formyl-2-oxo-propyl)-3-hydroxy-2-methyl-4,11-dioxo-1,5,8-trioxa-10-aza-spiro[5,5]undec-9-en-2-ylmethylamid}|3-methoxy-5-methyl-[1]naphthoic acid-{7-[(1-acetyl-aziridin-2-yl)-hydroxy-methyl]-9-(1-formyl-2-oxo-propyl)-3-hydroxy-2-methyl-4,11-dioxo-1,5,8-trioxa-10-aza-spiro[5,5]undec-9-en-2-ylmethylamide}

C31H33N3O12 (639.2064)

C25H41N3O16

C25H41N3O16 (639.2487)

Glu Lys Tyr Ser Asn

C27H41N7O11 (639.2864)

Glu Glu Thr Val Tyr

C28H41N5O12 (639.2752)

Thr Phe Glu Glu Asp

C27H37N5O13 (639.2388)

N2-iBu-DMT- dG

Guanosine, 5-O-[bis(4-methoxyphenyl)phenylmethyl]-2-deoxy-N-(2-methyl-1-oxopropyl)-

C35H37N5O7 (639.2693)

relative retention time with respect to 9-anthracene Carboxylic Acid is 1.363 5'-O-DMT-N2-ibu-dG (N2-Isobutyryl-5′-O-(4,4′-dimethoxytrityl)-2′-deoxyguanosine) is a deoxynucleoside which can be used in the preparation of oligonucleotides[1].

EETVY

Glu Glu Thr Val Tyr

C28H41N5O12 (639.2752)

EKYSN

Glu Lys Tyr Ser Asn

C27H41N7O11 (639.2864)

TFEED

Thr-Phe-Glu-Glu-Asp

C27H37N5O13 (639.2388)

HLDQQ

His Leu Asp Gln Gln

C26H41N9O10 (639.2976)

GalNAcβ1-4[Fucα1-3]GlcNAcβ-Sp

C24H41N5O15 (639.2599)

Tris[N,N-bis-(trimethylsilyl)amide]terbium(III)

C18H54N3Si6Tb (639.2187)

Abivertinib maleate

C30H34FN7O8 (639.2453)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

5-O-Dimethoxytrityl-benzoyl-2-deoxyguanosine

C35H37N5O7 (639.2693)

25-O-deacetyl-27-O-demethylrifamycin S

C34H41NO11 (639.2679)

(5Z,9alpha,13E,15S)-9-({(2R)-2-{[(4S)-4-azaniumyl-4-carboxylatobutanoyl]amino}-3-[(carboxylatomethyl)amino]-3-oxopropyl}sulfanyl)-15-hydroxy-11-oxoprosta-5,13-dien-1-oate

C30H45N3O10S-2 (639.2826)

(5Z,11alpha,13E,15S)-11-({(2R)-2-{[(4S)-4-azaniumyl-4-carboxylatobutanoyl]amino}-3-[(carboxylatomethyl)amino]-3-oxopropyl}sulfanyl)-15-hydroxy-9-oxoprosta-5,13-dien-1-oate

C30H45N3O10S-2 (639.2826)

(5Z,11beta,13E,15S)-11-({(2R)-2-{[(4S)-4-azaniumyl-4-carboxylatobutanoyl]amino}-3-[(carboxylatomethyl)amino]-3-oxopropyl}sulfanyl)-15-hydroxy-9-oxoprosta-5,13-dien-1-oate

C30H45N3O10S-2 (639.2826)

(5Z,9beta,13E,15S)-9-({(2R)-2-{[(4S)-4-azaniumyl-4-carboxylatobutanoyl]amino}-3-[(carboxylatomethyl)amino]-3-oxopropyl}sulfanyl)-15-hydroxy-11-oxoprosta-5,13-dien-1-oate

C30H45N3O10S-2 (639.2826)

(5S,6R,7E,9E,14Z)-6-({(2R)-2-{[(4S)-4-azaniumyl-4-carboxylatobutanoyl]amino}-3-[(carboxylatomethyl)amino]-3-oxopropyl}sulfanyl)-5-hydroxy-12-oxoicosa-7,9,14-trienoate

C30H45N3O10S-2 (639.2826)

LNAPS 25:7;O

C31H46NO11P (639.2808)

PS 18:4/7:3;O

C31H46NO11P (639.2808)

PS 25:7;O

C31H46NO11P (639.2808)

ST 23:4;O8;HexNAc

C31H45NO13 (639.2891)

DTP3 (TFA)

C28H36F3N7O7 (639.2628)

DTP3 TFA is a potent and selective GADD45β/MKK7 (growth arrest and DNA-damage-inducible β/mitogen-activated protein kinase kinase 7) inhibitor. DTP3 TFA targets an essential, cancer-selective cell-survival module downstream of the NF-κB pathway[1].

n-[2-({2-[(2,4-dicarbamimidamido-3,5,6-trihydroxycyclohexyl)oxy]-4-formyl-4-hydroxy-5-methyloxolan-3-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-2-hydroxy-n-methylacetamide

C23H41N7O14 (639.2711)

n-{[(9z)-7-[(1-acetylaziridin-2-yl)(hydroxy)methyl]-9-(1,3-dioxobutan-2-ylidene)-3,11-dihydroxy-2-methyl-4-oxo-1,5,8-trioxa-10-azaspiro[5.5]undec-10-en-2-yl]methyl}-3-methoxy-5-methylnaphthalene-1-carboximidic acid

n-{[(9z)-7-[(1-acetylaziridin-2-yl)(hydroxy)methyl]-9-(1,3-dioxobutan-2-ylidene)-3,11-dihydroxy-2-methyl-4-oxo-1,5,8-trioxa-10-azaspiro[5.5]undec-10-en-2-yl]methyl}-3-methoxy-5-methylnaphthalene-1-carboximidic acid

C31H33N3O12 (639.2064)

n-[(2s,3s,4s,5r,6s)-2-{[(2r,3s,4s,5r)-2-{[(1s,2r,3s,4s,5s,6r)-2,4-dicarbamimidamido-3,5,6-trihydroxycyclohexyl]oxy}-4-formyl-4-hydroxy-5-methyloxolan-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-2-hydroxy-n-methylacetamide

n-[(2s,3s,4s,5r,6s)-2-{[(2r,3s,4s,5r)-2-{[(1s,2r,3s,4s,5s,6r)-2,4-dicarbamimidamido-3,5,6-trihydroxycyclohexyl]oxy}-4-formyl-4-hydroxy-5-methyloxolan-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-2-hydroxy-n-methylacetamide

C23H41N7O14 (639.2711)

(1s,2z,16z,18e,20s,21s,22r,23s,24s,25r,28r,29s)-6,8,15,21,23,27,28-heptahydroxy-3,7,20,22,24,29-hexamethyl-26-oxa-14-azatetracyclo[23.2.2.1⁹,¹³.0⁵,¹⁰]triaconta-2,5,7,9,12,14,16,18-octaene-4,11,30-trione

(1s,2z,16z,18e,20s,21s,22r,23s,24s,25r,28r,29s)-6,8,15,21,23,27,28-heptahydroxy-3,7,20,22,24,29-hexamethyl-26-oxa-14-azatetracyclo[23.2.2.1⁹,¹³.0⁵,¹⁰]triaconta-2,5,7,9,12,14,16,18-octaene-4,11,30-trione

C34H41NO11 (639.2679)

(1s,2e,16z,18e,20s,21s,22r,23r,24r,25r,28r)-6,8,15,21,23,27,28-heptahydroxy-3,7,16,20,22,24-hexamethyl-26-oxa-14-azatetracyclo[23.2.2.1⁹,¹³.0⁵,¹⁰]triaconta-2,5,7,9,12,14,16,18-octaene-4,11,30-trione

(1s,2e,16z,18e,20s,21s,22r,23r,24r,25r,28r)-6,8,15,21,23,27,28-heptahydroxy-3,7,16,20,22,24-hexamethyl-26-oxa-14-azatetracyclo[23.2.2.1⁹,¹³.0⁵,¹⁰]triaconta-2,5,7,9,12,14,16,18-octaene-4,11,30-trione

C34H41NO11 (639.2679)

8-acetyl-1,6,8,11-tetrahydroxy-10-{[2-(2-hydroxypropyl)-4,10-dimethyl-2h,4h,6ah,7h,8h,10h,10ah-pyrano[3,4-d][1,3,6]dioxazocin-8-yl]oxy}-9,10-dihydro-7h-tetracene-5,12-dione

C33H37NO12 (639.2316)

n-({7-[(1-acetylaziridin-2-yl)(hydroxy)methyl]-9-(1,3-dioxobutan-2-ylidene)-3-hydroxy-2-methyl-4,11-dioxo-1,5,8-trioxa-10-azaspiro[5.5]undecan-2-yl}methyl)-3-methoxy-5-methylnaphthalene-1-carboximidic acid

n-({7-[(1-acetylaziridin-2-yl)(hydroxy)methyl]-9-(1,3-dioxobutan-2-ylidene)-3-hydroxy-2-methyl-4,11-dioxo-1,5,8-trioxa-10-azaspiro[5.5]undecan-2-yl}methyl)-3-methoxy-5-methylnaphthalene-1-carboximidic acid

C31H33N3O12 (639.2064)